Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 22, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Outlook Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 20
| |||||||
Outlook Therapeutics, Inc.
| 10K |
$1.83 | $18,300.00 | +112.03% | 18.93K | +3 |
Apr 20
| ||||||
Outlook Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| +3 |
Oct 1
| ||||||
Outlook Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| +3 |
Jul 17
| ||||||
Outlook Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| +3 |
Mar 19
| ||||||
Outlook Therapeutics, Inc.
| -1.35K |
$1.70 | -$2,295.00 | -13.14% | 8.93K | +3 |
Sep 18
| ||||||
Outlook Therapeutics, Inc.
| -1.35K |
$1.70 | -$2,295.00 | -1.64% | 80.86K | +3 |
Sep 18
| ||||||
Outlook Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| +3 |
Sep 12
| ||||||
Outlook Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| +3 |
Feb 19
| ||||||
Outlook Therapeutics, Inc.
| 25K |
$0.90 | $22,380.00 | +43.70% | 82.21K | +3 |
Feb 7
| ||||||
Oncobiologics, Inc.
| -10.10K |
$0.87 | -$8,807.20 | -15.00% | 57.21K | +3 |
Sep 18
| ||||||
Oncobiologics, Inc.
|
0
|
—
|
—
|
—
|
0
| +3 |
Aug 1
| ||||||
Oncobiologics, Inc.
| -26.16K |
$1.13 | -$29,566.45 | -27.99% | 67.31K |
Dec 22
| |||||||
Oncobiologics, Inc.
| 50K |
—
|
—
| +115.00% | 93.48K |
Dec 21
| |||||||
Oncobiologics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Oncobiologics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Arno Therapeutics, Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 24
| |||||||
Arno Therapeutics, Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Tamir Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Jul 23
| ||||||
Tamir Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Par Pharmaceutical Companies, Inc.
| -6.31K |
$26.90 | -$169,792.80 | -30.57% | 14.34K |
Aug 2
| |||||||
Par Pharmaceutical Companies, Inc.
|
0
|
$19.13 | -$260,361.62 |
—
| 20.65K | +1 |
Mar 3
| ||||||
Par Pharmaceutical Companies, Inc.
| -897.00 |
$25.88 | -$23,214.36 | -4.16% | 20.65K | +1 |
Jan 8
| ||||||
Par Pharmaceutical Companies, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Jan 4
| ||||||
Par Pharmaceutical Companies, Inc.
| 10.83K |
—
|
—
| +100.99% | 21.55K | +1 |
Jan 4
| ||||||
Par Pharmaceutical Companies, Inc.
| 10.72K |
—
|
—
|
∞
| 10.72K |
Jan 8
| |||||||
Par Pharmaceutical Companies, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Alfacell Corp
| 25K |
$2.14 | $53,381.32 |
∞
| 25K | +1 |
Apr 11
| ||||||
Alfacell Corp
|
0
|
—
|
—
|
—
|
0
| +1 |
Jan 16
| ||||||
Alfacell Corp
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Neopharm Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 25
| |||||||
Neopharm Inc
|
0
|
—
|
—
|
—
|
0
|
Apr 28
| |||||||
Neopharm Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 17
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.